140 related articles for article (PubMed ID: 33038911)
1. 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities.
Ojha M; Yadav D; Kumar A; Dasgupta S; Yadav R
Mini Rev Med Chem; 2021; 21(5):586-601. PubMed ID: 33038911
[TBL] [Abstract][Full Text] [Related]
2. 1,8-naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities.
Mithula S; Nandikolla A; Murugesan S; Kondapalli VG
Future Med Chem; 2021 Sep; 13(18):1591-1618. PubMed ID: 34256591
[TBL] [Abstract][Full Text] [Related]
3. 1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.
Madaan A; Verma R; Kumar V; Singh AT; Jain SK; Jaggi M
Arch Pharm (Weinheim); 2015 Dec; 348(12):837-60. PubMed ID: 26548568
[TBL] [Abstract][Full Text] [Related]
4. Discovery of gemifloxacin (Factive, LB20304a): a quinolone of a new generation.
Hong CY
Farmaco; 2001; 56(1-2):41-4. PubMed ID: 11347965
[TBL] [Abstract][Full Text] [Related]
5. Enoxacin: a potent inducer of filamentous Escherichia coli cells (a note).
Uri JV; Actor P
Acta Microbiol Hung; 1985; 32(2):197-200. PubMed ID: 3933273
[TBL] [Abstract][Full Text] [Related]
6. The bactericidal activity of gemifloxacin (SB-265805).
Morrissey I; Clark S; Mathias I
J Med Microbiol; 2000 Sep; 49(9):841-844. PubMed ID: 10966234
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
[TBL] [Abstract][Full Text] [Related]
8. 1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity.
Roma G; Di Braccio M; Grossi G; Piras D; Ballabeni V; Tognolini M; Bertoni S; Barocelli E
Eur J Med Chem; 2010 Jan; 45(1):352-66. PubMed ID: 19913952
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological activities of 1,8-naphthyridine derivatives.
Leonard JT; Gangadhar R; Gnanasam SK; Ramachandran S; Saravanan M; Sridhar SK
Biol Pharm Bull; 2002 Jun; 25(6):798-802. PubMed ID: 12081151
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas.
Pereyre S; Renaudin H; Bébéar C; Bébéar CM
Antimicrob Agents Chemother; 2004 Aug; 48(8):3165-8. PubMed ID: 15273141
[TBL] [Abstract][Full Text] [Related]
11. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
[TBL] [Abstract][Full Text] [Related]
12. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
[TBL] [Abstract][Full Text] [Related]
13. New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
Manera C; Malfitano AM; Parkkari T; Lucchesi V; Carpi S; Fogli S; Bertini S; Laezza C; Ligresti A; Saccomanni G; Savinainen JR; Ciaglia E; Pisanti S; Gazzerro P; Di Marzo V; Nieri P; Macchia M; Bifulco M
Eur J Med Chem; 2015 Jun; 97():10-8. PubMed ID: 25935384
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.
Waites KB; Crabb DM; Duffy LB
Int J Antimicrob Agents; 2003 Jun; 21(6):574-7. PubMed ID: 12791472
[TBL] [Abstract][Full Text] [Related]
15. 1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivative.
Di Braccio M; Grossi G; Alfei S; Ballabeni V; Tognolini M; Flammini L; Giorgio C; Bertoni S; Barocelli E
Eur J Med Chem; 2014 Oct; 86():394-405. PubMed ID: 25194932
[TBL] [Abstract][Full Text] [Related]
16. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.
Karrouchi K; Radi S; Ramli Y; Taoufik J; Mabkhot YN; Al-Aizari FA; Ansar M
Molecules; 2018 Jan; 23(1):. PubMed ID: 29329257
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Hardy D; Amsterdam D; Mandell LA; Rotstein C
Antimicrob Agents Chemother; 2000 Mar; 44(3):802-5. PubMed ID: 10681365
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Neisseria meningitidis isolates to gemifloxacin and ten other antimicrobial agents.
Vázquez JA; Berrón S; Giménez MJ; de la Fuente L; Aguilar L
Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):150-1. PubMed ID: 11305475
[No Abstract] [Full Text] [Related]
20. Naphthyridines with Antiviral Activity - A Review.
Singh IP; Kumar S; Gupta S
Med Chem; 2017; 13(5):430-438. PubMed ID: 28031019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
